Unique ID issued by UMIN | UMIN000006818 |
---|---|
Receipt number | R000008062 |
Scientific Title | A multicenter, single-arm phase II trial of bevacizumab beyond initial progression in patients treated with first-line mFOLFOX6 followed by second-line FOLFIRI in Advanced Colorectal Cancer |
Date of disclosure of the study information | 2011/12/01 |
Last modified on | 2016/11/16 08:52:16 |
A multicenter, single-arm phase II trial of bevacizumab beyond initial progression in patients treated with first-line mFOLFOX6 followed by second-line FOLFIRI in Advanced Colorectal Cancer
CCOG-0801
A multicenter, single-arm phase II trial of bevacizumab beyond initial progression in patients treated with first-line mFOLFOX6 followed by second-line FOLFIRI in Advanced Colorectal Cancer
CCOG-0801
Japan |
untreated and unresectable metastatic colorectal cancer
Gastroenterology | Gastrointestinal surgery |
Malignancy
NO
To explore the efficacy and safety of bevacizumab beyond initial progression in patients treated with first-line mFOLFOX6 followed by second-line FOLFIRI in advanced colorectal cancer
Safety,Efficacy
Exploratory
Pragmatic
Phase II
2nd progression free survival (2nd PFS)
Progression free survival (PFS),overall survival (OS), response rate (ORR), disease control rate (DCR) and safty
Interventional
Single arm
Non-randomized
Open -no one is blinded
Uncontrolled
1
Treatment
Medicine |
bevacizumab plus mFOLFOX6 therapy (first-line treatment)
bevacizumab plus FOLFIRI therapy (second-line treatment)
20 | years-old | <= |
74 | years-old | >= |
Male and Female
1. Histologically confirmed colorectal adenocarcinoma.
2. Unresectable metastatic disease.
3. Age 20 to 74 years.
4. Eastern Cooperative Oncology Group (ECOG) performance status of 0 or 1
5. No previous chemotherapy for mCRC.
6. Bidimensionally measurable disease.
7. A life expectancy of at least 3 months
8. Written informed consent was obtained.
9. Adequate organ function.
1. Previous history of severe drug-induced allergy
2. Brain metastasis
3. Cerebrovascular disease or its symptoms within 1 year.
4. Massive pleural effusion or ascites that required drainage.
5. History of active double cancer.
6. Previous history of thoromboembolitic disease, or necessity for antithrombotic drug.
7. Intestinal bleeding, ileus, bowel obstruction or uncontrolled peptic ulcer.
8. History of gastrointestinal perforation within 1 year.
9. Diathesis of bleeding (history of hemoptysis, including cavitation and/or necrosis in lung metastasis confirmed by imaging), coagulopathy.
10. Severe renal failure or urinary protein (more than 2+).
11. Uncontrolled severe complications (DM, hypertension, diarrhea, et al.).
12. Patient with symptomatic cardiovascular disease or asymptomatic disease but have been treated (>=Grade 2 according to NCI-CTCAE ver.4). History of myocardial infarction within a year.
13. Interstitial lung disease or pulmonary fibrosis.
14. Uncontrolled infection.
15. Patient receiving surgical procedure or such as skin-open biopsy, trauma surgery, or other more intensive surgeries within 4 weeks or aspiration biopsy within a week.
16. Pregnant women, possibly pregnant women, wishing to become pregnant, and nursing mothers.
17. Not appropriate for the study at the physician's assessment.
50
1st name | |
Middle name | |
Last name | Goro Nakayama |
Nagoya University Graduate School of Medicine
Department of Gastroenterological Surgery
65 Tsurumai-chi, Showa-ku, Nagoya, Japan
0527442250
goro@med.nagoya-u.ac.jp
1st name | |
Middle name | |
Last name | Goro Nakayama |
Nagoya University Graduate School of Medicine
Department of Gastroenterological Surgery
65 Tsurumai-chi, Showa-ku, Nagoya, Japan
0527442250
goro@med.nagoya-u.ac.jp
Chubu Clinical Oncology Group (CCOG)
Chubu Clinical Oncology Group (CCOG)
Self funding
NO
2011 | Year | 12 | Month | 01 | Day |
Published
http://www.ncbi.nlm.nih.gov/pubmed/22886005
Completed
2008 | Year | 05 | Month | 29 | Day |
2008 | Year | 08 | Month | 01 | Day |
2013 | Year | 12 | Month | 15 | Day |
2013 | Year | 12 | Month | 15 | Day |
2013 | Year | 12 | Month | 15 | Day |
2013 | Year | 12 | Month | 31 | Day |
2011 | Year | 12 | Month | 01 | Day |
2016 | Year | 11 | Month | 16 | Day |
Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000008062
Research Plan | |
---|---|
Registered date | File name |
Research case data specifications | |
---|---|
Registered date | File name |
Research case data | |
---|---|
Registered date | File name |